Matt Wade
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Recent Post
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
